PANCREAS ADENOCARCINOMA
Clinical trials for PANCREAS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREAS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREAS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo aims to shrink tough pancreatic tumors before surgery
Disease control Recruiting nowThis study tests whether alternating two different chemotherapy combinations before surgery can better shrink borderline pancreatic tumors. The goal is to make more tumors removable by surgery and reduce the chance of cancer returning. About 35 adults with borderline pancreatic c…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Blood test guides aggressive attack on spreading stomach and pancreatic cancers
Disease control Recruiting nowThis study is for people with advanced cancer that started in the upper digestive tract (like the stomach, pancreas, or bile ducts) and has spread to only a few other places. After three months of chemotherapy, if a special blood test finds no cancer DNA, patients are randomly as…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New attack plan for pancreatic cancer: hit hard before surgery
Disease control Recruiting nowThis study is testing a new treatment plan for people with pancreatic cancer that can be removed by surgery. The goal is to see if giving strong chemotherapy and targeted radiation *before* the operation helps surgeons remove all the cancer cells more effectively. Researchers wil…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Loma Linda University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug sequence aims to make inoperable pancreatic tumors removable
Disease control Recruiting nowThis study is testing whether giving two different chemotherapy combinations in sequence can better shrink pancreatic tumors that are difficult or impossible to remove with surgery. The goal is to see if this approach makes more tumors operable and improves survival. The trial wi…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Three-Pronged attack aims to stop dangerous leaks after major cancer surgery
Disease control Recruiting nowThis international study is testing whether a combination of three existing treatments can reduce serious complications after a complex surgery to remove pancreatic tumors. The surgery, called a pancreatoduodenectomy, has a high risk of a dangerous fluid leak. The trial will enro…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Genetic clues may predict pancreatic cancer treatment success
Disease control Recruiting nowThis study is testing whether genetic analysis of pancreatic tumors can predict how well patients respond to chemotherapy before surgery. Researchers will give 45 patients with non-metastatic pancreatic cancer a standard chemotherapy combination called FOLFIRINOX, then analyze tu…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Scientists hunt genetic clues to stop Cancer's devastating weight loss
Knowledge-focused Recruiting nowThis study aims to understand why most pancreatic cancer patients experience severe, life-threatening weight loss called cachexia. Researchers will collect genetic samples from 100 patients with advanced pancreatic cancer to look for DNA patterns linked to this condition. The goa…
Matched conditions: PANCREAS ADENOCARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC